CoverageForm 410-K10-Q8-K13D13G13F

Garg Pushkal

CIK 0001829252
EVP Chief R&DDirector

Filings

26

Latest Mar 6, 2026

Issuers covered

2

Showing

26 of 26

Page 1

Track record

180 of 180 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).

HorizonTradesWin rateAvgMedianBestWorst
30 days18059%+1.2%+1.1%+17.9%-9.6%
90 days18061%-0.2%+2.2%+13.7%-26.0%
180 days12741%-23.8%-0.9%+28.2%-84.1%
365 days9613%-31.9%-33.1%+26.9%-75.7%

Issuers

Companies where Garg Pushkal has filed

TickerIssuerFilingsLast filed
ALNYAlnylam Pharmaceuticals, Inc.24Mar 6, 2026
SQZSqz Biotechnologies Co2Jun 15, 2023

All filings

26 Form 4 / 4-A filings, newest first

Sign in to download
Filed Top transactionSharesPriceValue